|Legal Status||To be confirmed|
A 2-chloro derivative of diazepam which is not licensed for medicinal use.
There is a lack of published scientific evidence for this substance and no cases of poisoning have been documented in the literature (Toxbase 28/08/14).
|Short Term Effects||
Benzodiazepines commonly cause drowsiness, ataxia, dysarthria and nystagmus. Coma, hypotension, bradycardia and respiratory depression occasionally occur but are seldom serious if these drugs are taken alone. Coma usually lasts only a few hours but may be prolonged in elderly patients. Benzodiazepine respiratory depressant effects are more serious in patients with severe chronic obstructive airways disease. Severe effects in overdose also include rhabdomyolysis and hypothermia. Co-ingestion of alcohol and other central nervous system depressants potentiates the effects of benzodiazepines and can increase toxicity.
Identified in Sweden: 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one (norfludiazepam). Norfludiazepam is a benzodiazepine and is structurally related to the internationally controlled substance diazepam.
WEDINOS Service upgrade…: Great news following Welsh Governments recent funding of the project until 2025, all our new analytical tools are in place. Our analysts have completed their training and familiarisation and will, over the next fortnight, be working through the backlog of samples generated as a result of this necessary pause in service. Normal testing and service turnaround times should resume at the beginning of June. We thank you for your continued support and patience.